Unknown

Dataset Information

HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitor.


ABSTRACT:

Objective

While immune checkpoint inhibitors are increasingly used for various cancers, unpredictable immune-related adverse events (irAEs) such as autoimmune encephalitis is life-threatening. Here, we report an association between human leukocyte antigen (HLA) and atezolizumab-induced encephalitis.

Methods

From an institutional prospective cohort for encephalitis, we identified patients with autoimmune encephalitis after the use of atezolizumab, a PD-L1 (programmed death-ligand 1) inhibitor, from August 2016 to September 2019 and analyzed their HLA genotypes.

Results

A total of 290 patients received atezolizumab, and seven patients developed autoimmune encephalitis, and five of whom were enrolled for the analysis. The patients presented altered mentality, seizures, o

SUBMITTER: Chang H 

PROVIDER: S-EPMC7664281 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature